Doliver Advisors’s AbbVie ABBV Stock Holding History

Doliver Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$934K	Sell	5,029 -44	-0.9%	-$8.17K	0.26%	70
2025 Q1	$1.06M	Sell	5,073 -203	-4%	-$42.5K	0.3%	58
2024 Q4	$938K	Buy	5,276 +59	+1%	+$10.5K	0.26%	62
2024 Q3	$1.03M	Sell	5,217 -949	-15%	-$187K	0.28%	58
2024 Q2	$1.06M	Buy	6,166 +2	+0%	+$343	0.3%	58
2024 Q1	$1.12M	Sell	6,164 -8	-0.1%	-$1.46K	0.32%	58
2023 Q4	$957K	Buy	6,172 +2	+0%	+$310	0.29%	61
2023 Q3	$920K	Sell	6,170 -468	-7%	-$69.8K	0.28%	62
2023 Q2	$894K	Sell	6,638 -118	-2%	-$15.9K	0.27%	67
2023 Q1	$1.08M	Buy	6,756 +2	+0%	+$319	0.34%	52
2022 Q4	$1.09M	Buy	6,754 +1	+0%	+$162	0.36%	46
2022 Q3	$906K	Sell	6,753 -503	-7%	-$67.5K	0.33%	52
2022 Q2	$1.11M	Sell	7,256 -1,789	-20%	-$274K	0.39%	44
2022 Q1	$1.47M	Sell	9,045 -5,284	-37%	-$856K	0.46%	36
2021 Q4	$2.02M	Sell	14,329 -3,186	-18%	-$448K	0.63%	20
2021 Q3	$1.89M	Buy	17,515 +1,332	+8%	+$144K	0.63%	23
2021 Q2	$1.82M	Buy	16,183 +723	+5%	+$81.4K	0.6%	23
2021 Q1	$1.67M	Buy	15,460 +1,124	+8%	+$122K	0.62%	27
2020 Q4	$1.54M	Buy	14,336 +1,028	+8%	+$110K	0.68%	27
2020 Q3	$1.17M	Buy	13,308 +460	+4%	+$40.3K	0.59%	30
2020 Q2	$1.26M	Buy	12,848 +189	+1%	+$18.6K	0.56%	33
2020 Q1	$1.07M	Sell	12,659 -1,432	-10%	-$121K	0.53%	33
2019 Q4	$1.25M	Sell	14,091 -86	-0.6%	-$7.62K	0.49%	32
2019 Q3	$1.06M	Buy	14,177 +751	+6%	+$55.9K	0.42%	36
2019 Q2	$976K	Buy	13,426 +190	+1%	+$13.8K	0.38%	30
2019 Q1	$1.07M	Buy	13,236 +571	+5%	+$46K	0.43%	26
2018 Q4	$1.17M	Sell	12,665 -297	-2%	-$27.4K	0.57%	16
2018 Q3	$1.23M	Buy	12,962 +1,144	+10%	+$108K	0.51%	23
2018 Q2	$1.1M	Buy	11,818 +431	+4%	+$39.9K	0.46%	22
2018 Q1	$1.08M	Sell	11,387 -599	-5%	-$56.7K	0.47%	21
2017 Q4	$1.16M	Sell	11,986 -1,030	-8%	-$99.6K	0.46%	23
2017 Q3	$1.16M	Buy	13,016 +2,329	+22%	+$207K	0.52%	35
2017 Q2	$775K	Buy	+10,687	New	+$775K	0.37%	62